X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ARDX

Closed

Ardelyx Inc

3.9
0.0 (0.00%)
Last Update: 01 Jul 2025 23:14:00
Yesterday: 3.92
Day's Range: 3.8 - 4.055
Send
When Written:
 
4.79
Ardelyx Inc. is a biopharmaceutical company that develops and commercializes innovative medicines for the treatment of kidney and cardiovascular diseases. The company's lead product candidate, tenapanor, is a small molecule inhibitor of the sodium-hydrogen exchanger 3 (NHE3) that is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Ardelyx is also developing a pipeline of other NHE3 inhibitors for the treatment of various other conditions, including heart failure, hypertension, and irritable bowel syndrome with constipation (IBS-C). The company was founded in 2007 and is headquartered in Fremont, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X